EPAS1 and diabetic kidney disease: Besides, SGLT2 inhibitors upregulate SIRT1 (Umino et al., 2018) and HIF-2α (Chen et al., 2011; Chen et al., 2012) in DKD, which would also contribute to ameliorate the autophagy stagnation.